Recall D-0056-2024
Description: Moxifloxacin in Balanced Salt Solution, Solution for Intraocular Injection, 600 mcg/0.4mL (150 mcg/0.1mL) Syringe, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
Recall D-0056-2024 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0056-2024 |
Event ID | 93154 |
Distribution | Nationwide within the United States |
Quantity | 2484 syringes |
Recall Reason | Lack of Assurance of Sterility |
Drug Classification | Class II |
Drug Code Info | 20231025 |
Recall Initiation Date | 20231002 |
Report Date | 20231025 |
Classification Date | 20231019 |
Address | 355 Riverwalk Pkwy Tonawanda, NY 14150-5837 United States |
Recalling Firm | Pine Pharmaceuticals, LLC |
Initial Notification | Letter |
Similar To |